Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 23 M26 M27 M27 M25 M 105 M Research & development ————— — Operating income 18 M6 M26 M-3 M24 M 53 M Non-Operating Income, Total -17 M-19 M-26 M-36 M-8 M -89 M Interest expense, net of interest capitalized 15 M15 M15 M24 M15 M 69 M Non-Operating Income, excl. Interest Expenses -3 M-6 M-22 M-26 M-9 M -63 M Unusual income/expense -14 M-13 M-4 M-10 M1 M -26 M Pretax income 1 M-13 M0-39 M16 M -36 M Equity in earnings 8 M6 M-11 M-13 M4 M -14 M Taxes 15 M29 M11 M-29 M23 M 34 M Non-controlling/minority interest ————— — After tax other income/expense -12 M-15 M04 M0 -11 M Net income before discontinued operations -14 M-42 M-11 M-10 M-7 M -70 M Discontinued operations ————— — Net income -14 M-42 M-11 M-10 M-7 M -70 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -13 M-41 M-10 M-8 M-6 M -65 M Basic earnings per share (Basic EPS) -0.23-0.68-0.17—-0.11 — Diluted earnings per share (Diluted EPS) -0.23-0.68-0.17-0.15-0.11 -1.11 Average basic shares outstanding 62 M62 M62 M62 M62 M — Diluted shares outstanding 65 M65 M65 M65 M65 M — EBITDA 73 M62 M84 M87 M95 M 328 M EBIT 18 M6 M26 M18 M24 M 74 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 55 M56 M58 M69 M71 M 254 M